{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:50:05Z","timestamp":1792497005525,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 HL075462"],"award-info":[{"award-number":["P01 HL075462"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["SIG S10RR027431\u201001"],"award-info":[{"award-number":["SIG S10RR027431\u201001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UC4DK116264"],"award-info":[{"award-number":["UC4DK116264"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K16409"],"award-info":[{"award-number":["21K16409"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014547","name":"Parker Institute for Cancer Immunotherapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1111\/ajt.17181","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T21:08:11Z","timestamp":1661720891000},"page":"3061-3068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["IL-2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitor"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3343-6674","authenticated-orcid":false,"given":"Toshihito","family":"Hirai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0696-7197","authenticated-orcid":false,"given":"Teresa L.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Simonetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon L.","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora K.","family":"Picton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane K.","family":"Lohmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Christopher","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Negrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1111\/ajt.17181_bib1","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1172\/JCI90598","article-title":"Transplant trials with Tregs: perils and promises","volume":"127","author":"Tang","year":"2017","journal-title":"J Clin Invest."},{"issue":"11","key":"10.1111\/ajt.17181_bib2","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1111\/ajt.14415","article-title":"Polyclonal regulatory T cell therapy for control of inflammation in kidney transplants","volume":"17","author":"Chandran","year":"2017","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.17181_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology."},{"issue":"10237","key":"10.1111\/ajt.17181_bib4","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (the ONE study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet."},{"issue":"12","key":"10.1111\/ajt.17181_bib5","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1111\/j.1600-6143.2012.04269.x","article-title":"Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients","volume":"12","author":"Akimova","year":"2012","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1111\/ajt.17181_bib6","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1097\/TP.0000000000001379","article-title":"Impact of immune-modulatory drugs on regulatory T cell","volume":"100","author":"Furukawa","year":"2016","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.17181_bib7","first-page":"136","article-title":"Effects of FK506 and cyclosporin a on cytokine production studied in vitro at a single-cell level","volume":"75","author":"Andersson","year":"1992","journal-title":"Immunology."},{"issue":"9","key":"10.1111\/ajt.17181_bib8","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.4049\/jimmunol.1102376","article-title":"Constitutive nuclear localization of NFAT in Foxp3+ regulatory T cells independent of calcineurin activity","volume":"188","author":"Li","year":"2012","journal-title":"J Immunol."},{"issue":"27","key":"10.1111\/ajt.17181_bib9","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1073\/pnas.1620835114","article-title":"IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors","volume":"114","author":"Whitehouse","year":"2017","journal-title":"Proc Natl Acad Sci."},{"issue":"18","key":"10.1111\/ajt.17181_bib10","first-page":"e89278","article-title":"Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells","volume":"1","author":"Hirakawa","year":"2017","journal-title":"JCI Insight."},{"issue":"6379","key":"10.1111\/ajt.17181_bib11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1126\/science.aar3246","article-title":"Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes","volume":"359","author":"Sockolosky","year":"2018","journal-title":"Science."},{"issue":"8","key":"10.1111\/ajt.17181_bib12","doi-asserted-by":"crossref","first-page":"e139991","DOI":"10.1172\/JCI139991","article-title":"Selective expansion of regulatory T cells using an orthogonal IL-2\/IL-2 receptor system facilitates transplantation tolerance","volume":"131","author":"Hirai","year":"2021","journal-title":"J Clin Invest."},{"issue":"11","key":"10.1111\/ajt.17181_bib13","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/bloodadvances.2020003272","article-title":"Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD","volume":"5","author":"Hirai","year":"2021","journal-title":"Blood Adv."},{"issue":"13","key":"10.1111\/ajt.17181_bib14","doi-asserted-by":"crossref","first-page":"e145360","DOI":"10.1172\/jci.insight.145360","article-title":"Imaging alloreactive T cells provides early warning of organ transplant rejection","volume":"6","author":"Hirai","year":"2021","journal-title":"JCI Insight."},{"issue":"528","key":"10.1111\/ajt.17181_bib15","doi-asserted-by":"crossref","first-page":"eaax8863","DOI":"10.1126\/scitranslmed.aax8863","article-title":"Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal","volume":"12","author":"Busque","year":"2020","journal-title":"Sci Transl Med."},{"issue":"4","key":"10.1111\/ajt.17181_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOT.0b013e328355a992","article-title":"Regulatory T-cell therapy for transplantation: how many cells do we need?","volume":"17","author":"Tang","year":"2012","journal-title":"Curr Opin Organ Transplant."},{"issue":"4","key":"10.1111\/ajt.17181_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/tri.13390","article-title":"Evaluation of the impact of conventional immunosuppressant on the establishment of murine transplantation tolerance \u2013 an experimental study","volume":"32","author":"Katsumata","year":"2019","journal-title":"Transpl Int."},{"issue":"10","key":"10.1111\/ajt.17181_bib18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat Rev Drug Discov."},{"issue":"22","key":"10.1111\/ajt.17181_bib19","doi-asserted-by":"crossref","first-page":"14179","DOI":"10.1128\/JVI.79.22.14179-14188.2005","article-title":"Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli","volume":"79","author":"Swiggard","year":"2005","journal-title":"J Virol."},{"issue":"7","key":"10.1111\/ajt.17181_bib20","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia."},{"issue":"7714","key":"10.1111\/ajt.17181_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature."},{"issue":"2","key":"10.1111\/ajt.17181_bib22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nprot.2017.143","article-title":"CRISPR\/Cas9 genome editing in human hematopoietic stem cells","volume":"13","author":"Bak","year":"2018","journal-title":"Nat Protoc."},{"key":"10.1111\/ajt.17181_bib23","doi-asserted-by":"crossref","first-page":"eabg6986","DOI":"10.1126\/scitranslmed.abg6986","article-title":"A human orthogonal IL-2 and IL-2R\u03b2 system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia","volume":"13","author":"Zhang","year":"2021","journal-title":"Sci Transl Med."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.17181","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.17181","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613523000576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613523000576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.17181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:50:16Z","timestamp":1761580216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613523000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1600613523000576"],"URL":"https:\/\/doi.org\/10.1111\/ajt.17181","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitor","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.17181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}